Annual Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation
About This Course:
We are pleased to announce that our highly acclaimed Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation will be resuming in the Spring of 2024. This course is a highly interactive online program, held on six separate days, over a three-week period.
This course is designed to provide participants with a comprehensive understanding of the drug development process, from initial discovery through to regulatory approval and post-marketing surveillance. Whether you are new to the industry or need a refresher, the program will provide you with instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation.
We invite you to join us for this exciting opportunity to further your education and advance your career in the field of clinical pharmacology, drug development, and regulation. Stay tuned for more information on the program details.
Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.
Drug Development and Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies and analyze an experimental design for a new drug candidate.
Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the U.S., Europe, Japan and other pharmaceutical markets.
Date: Spring 2024, Coming Soon!
Who Should Attend?
Physicians, pharmacists, marketing executives, clinical researchers, nurses, analysts, investors, and any professional working with or in the research-based drug industry
Professionals looking to begin work in the pharma or biotech sectors and seeking comprehensive and foundational industry knowledge and training
Individuals employed by regulatory agencies, academic institutions, outsourcing providers, consultancy firms, niche service providers, and other organizations involved in the research, development, and regulation of pharmaceutical products
Earn a Digital Course Completion Badge & Certificate!
- Showcase the knowledge and skills you acquired from the program.
- Share your learning achievements with clients, employers, and colleagues on online platforms and social media networks like LinkedIn, Facebook and Twitter.
Course Overview and Goals
The 2023 Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation is an interactive online program, moderated by professor of medicine and CSDD senior fellow, Dr. Kenneth I Kaitin. The goal of the course is to provide a fundamental overview of pharmaceutical development and regulation, focusing on topics vital to professionals involved in all aspects of bioinnovation. The six-day program, held over three weeks in February 2023, provides advanced instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation. Taught by an outstanding slate of seasoned lecturers from academia, industry, government, and consulting, the program focuses on topics vital to professionals involved in all aspects of pharmaceutical research, development, manufacturing and marketing. Participants include individuals employed in the pharma and biotechnology industries, regulatory agencies, government research centers, academia, outsourcing providers, consultancies, law and investment firms, and other organizations involved in the research, development, regulation, and marketing of pharmaceutical products.
Kenneth Kaitin, PhD
Kenneth Kaitin is Professor of Medicine at Tufts University School of Medicine and Senior Fellow at Tufts Center for the Study of Drug Development, where he previously served as Director for 23 years. He is also an Advisory Professor at Shanghai Medical College at Fudan University in China, and serves on the faculties of the European Center for Pharmaceutical Medicine at the University of Basel, the American Course on Drug Development and Regulatory Science at the University of California, San Francisco, and the IFAPP Academy-Kings College London Medical Affairs in Medicines Development Certification Program. Dr. Kaitin is internationally recognized for his contributions to the field of drug development policy and science. He consults, speaks, and writes on global trends in pharmaceutical development, and has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, Dr. Kaitin served as Editor-in-Chief of Expert Review of Clinical Pharmacology, and as a consultant to the U.S. Department of Defense on bioterror countermeasures. In 2011 he received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators; in 2020, he was named Global Fellow in Medicines Development by the International Federation of Pharmaceutical Physicians in 2020; and in 2021, he received the Distinguished Achievement Award from the Sino-American Pharmaceutical Professionals Association (SAPA). Dr. Kaitin is a director on the boards of Curis, Inc. (NASDAQ: CRIS), Bio-Tree Systems, Inc., and QCDx LLC. He earned his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.
"Taking the Tufts course was a tremendously beneficial experience for me. I'm so grateful to have learned so much and met such wonderful colleagues. You created a fantastic roster of speakers and presentations." Past Participant
“Being new to the industry I appreciated that all the presentations provided excellent background information before examining each topic in more depth.” Past Participant
“The Regulation overview for U.S., E.U., Japan, and China were extremely useful. The presentation captured essential knowledge for those areas.” Past Participant
“The mock drug groups activity was very helpful because it brought together a handful of people from different backgrounds and professions. It encouraged team-building and communication — two things that are very much needed in the work field.” Past Participant
GET MORE INFORMATION
Have any questions? Enter your information below to get in touch with our enrollment team.